v2.4.0.6
Business Segments and Geographic Information
 6 Months Ended
Mar. 30, 2013
Segment Reporting [Abstract]  
Business Segments and Geographic Information

(12) Business Segments and Geographic Information

The Company has four reportable segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income (loss) adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, contingent consideration charges, restructuring and divestiture charges and other one-time or unusual items and related tax effects.

Identifiable assets for the four principal operating segments consist of inventories, intangible assets including goodwill, and property and equipment. The Company fully allocates depreciation expense to its four reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues during the three and six months ended March 30, 2013 and March 24, 2012. Segment information is as follows:

 

     Three Months Ended     Six Months Ended  
     March 30,
2013		     March 24,
2012		     March 30,
2013		     March 24,
2012		  

Total revenues:

         

Diagnostics

    $ 296,507      $ 151,841      $ 602,423      $ 305,905   

Breast Health

      220,058        218,631        440,866        433,983   

GYN Surgical

      73,692        77,178        154,601        155,723   

Skeletal Health

      22,406        23,515        46,135        48,265   
  

 

 

    

 

 

    

 

 

    

 

 

  
   $ 612,663      $ 471,165      $ 1,244,025      $ 943,876   
  

 

 

    

 

 

    

 

 

    

 

 

  

Operating income (loss):

         

Diagnostics

    $ (46,978 )    $ 21,619      $ (32,683 )    $ 41,757   

Breast Health

      47,892        48,869        92,837        96,286   

GYN Surgical

      2,241        (63,377 )     2,863        (68,390 ) 

Skeletal Health

      2,387        3,023        5,754        7,240   
  

 

 

    

 

 

    

 

 

    

 

 

  
   $ 5,542      $ 10,134      $ 68,771      $ 76,893   
  

 

 

    

 

 

    

 

 

    

 

 

  

Depreciation and amortization:

         

Diagnostics

    $ 89,402      $ 39,926      $ 180,944      $ 79,915   

Breast Health

      10,124        10,470        20,054        21,074   

GYN Surgical

      26,524        26,217        53,003        52,305   

Skeletal Health

      226        428        430        870   
  

 

 

    

 

 

    

 

 

    

 

 

  
   $ 126,276      $ 77,041      $ 254,431      $ 154,164   
  

 

 

    

 

 

    

 

 

    

 

 

  

Capital expenditures:

         

Diagnostics

    $ 13,464      $ 9,455      $ 27,318      $ 17,623   

Breast Health

      5,910        2,213        9,490        3,782   

GYN Surgical

      2,171        3,251        4,916        6,000   

Skeletal Health

      28        9        206        466   

Corporate

      2,823        2,823        4,913        5,686   
  

 

 

    

 

 

    

 

 

    

 

 

  
   $ 24,396      $ 17,751      $ 46,843      $ 33,557   
  

 

 

    

 

 

    

 

 

    

 

 

  

 

     March 30,
2013		      September 29,
2012		  

Identifiable assets:

      

Diagnostics

    $ 5,951,165       $ 6,170,553   

Breast Health

      957,783         956,134   

GYN Surgical

      1,898,933         1,944,386   

Skeletal Health

      34,156         32,778   

Corporate

      1,467,169         1,373,257   
  

 

 

     

 

 

  
   $ 10,309,206       $ 10,477,108   
  

 

 

     

 

 

  

The Company had no customers with balances greater than 10% of accounts receivable as of March 30, 2013 or September 29, 2012, or any customer that represented greater than 10% of consolidated revenues during the three and six months ended March 30, 2013 and March 24, 2012.

 

Products sold by the Company internationally are manufactured at both domestic and international locations. Transfers between the Company and its subsidiaries are generally recorded at amounts similar to the prices paid by unaffiliated foreign dealers. All intercompany profit is eliminated in consolidation.

The Company operates in the major geographic areas as noted in the below chart. Revenue data is based upon customer location, and internationally totaled $153.5 million and $323.6 million during the three and six months ended March 30, 2013, respectively, and totaled $117.5 million and $235.0 million during the three and six months ended March 24, 2012, respectively. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from Germany, the United Kingdom and the Netherlands. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “All others” designation includes Canada, Latin America and the Middle East.

Revenues by geography as a percentage of total revenues was as follows:

 

     Three Months Ended     Six Months Ended  
     March 30,
2013		     March 24,
2012		     March 30,
2013		     March 24,
2012		  

United States

      75 %     75 %     74 %     75 %

Europe

      12 %     11 %     14 %     12 %

Asia

      9 %     8 %     8 %     8 %

All others

      4 %     6 %     4 %     5 %
  

 

 

    

 

 

    

 

 

    

 

 

  
     100 %     100 %     100 %     100 %